Table 5.  Comparison of clinical and economic primary outcomes.

Outcomes	Low dose of rehabilitation (mean rats <3.6), n=27	High dose of rehabilitation (mean rats >3.6), n=27	P-value	Adjusted P-value
Primary outcome
ADL dependence at discharge, n (%)	22 (81)	6 (22)	<0.001	<0.001
Secondary outcomes
Clinical outcomes and physical assessment
Total medical costs (US dollars), median [IQR]	26335 [19726–39603]	28042 [16935–40410]	0.993	0.976
Duration of mechanical ventilation (days), median [IQR]	6 [5–9]	4 [2–6]	0.007	0.076
ICU length of stay (days), median [IQR]	8 [6–9]	7 [6–11]	0.931	0.905
Hospital length of stay (days), median [IQR]	33 [27–43]	28 [22–56]	0.539	0.658
Discharge to home, n (%)	15 (56)	18 (67)	0.402	0.299
Hospital survival, n (%)	27 (100)	24 (89)	0.236	0.999
ICU-AW at ICU discharge, n (%)	19 (70)	10 (37)	0.028	0.016
Delirium during ICU stay, n (%)	8 (30)	4 (15)	0.327	0.130
Rehabilitation in ICU and Ward
Time to first rehabilitation from the ICU admission (days)	2 [1–3]	2 [1–3]	0.473	0.529
Time to first meet the criteria for mobilization from the ICU admission (days)	6 [5–7]	4 [3–6]	0.006	<0.001
Time to first out of bed mobilization from the ICU admission (days)	8 [5–9]	4 [3–7]	0.014	0.058
The highest ICU mobility scale during ICU stay (score)	1 [1–3]	7 [5–10]	<0.001	<0.001
Achieved mobilization within 7 days from the ICU admission	10 (37)	21 (78)	0.005	0.002
Number of daily rehabilitation sessions per person during ward care	1 [1–1]	1 [1–1]	0.256	0.298

Data are presented as median [interquartile range] or number (%).

ICU-AW, intensive care unit acquired weakness.